共 50 条
- [25] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) LIVERS, 2023, 3 (04): : 597 - 617
- [27] The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):